| Institute for Research & Innovation |
Diabetes - Heart Disease
Study Number: 12-END-04Age: 18 yrs or older
Sex: Males and Females
Visits: 8 Study Visits and 14 telephone visits
Stipend: You will be compensated for your time and travel
Principal Investigator(s): Ronald Graf, MD
Study Coordinator: Denise Quinn, Research Coordinator 253-301-6991
Purpose: To evaluate the ability of an Investigational Lipid lowering medication verses placebo to reduce cardiovascular events in patients with established Coronary Vascular Disease or High Risk Cardiovascular Disease and preventing the occurrence of first major cardiovascular event.